Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis - Archive ouverte HAL Access content directly
Poster Communications Year : 2022

Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis

Domains

Immunology
Bayer Alexandra Myology 2022 Nice.pdf (68.92 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03824304 , version 1 (21-10-2022)

Identifiers

  • HAL Id : hal-03824304 , version 1

Cite

Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩
42 View
17 Download

Share

Gmail Facebook X LinkedIn More